| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.003 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |